Avaii Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Avaii Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$214K	Sell	1,674 -2,765	-62%	-$345K	0.07%	152
2025 Q4	$541K	Sell	4,439 -59	-1%	-$6.76K	0.2%	67
2025 Q3	$451K	Buy	4,498 +1,709	+61%	+$154K	0.17%	82
2025 Q2	$231K	Sell	2,789 -65	-2%	-$5.18K	0.1%	118
2025 Q1	$231K	Sell	2,854 -189	-6%	-$16.9K	0.12%	110
2024 Q4	$274K	Sell	3,043 -37	-1%	-$3.58K	0.13%	105
2024 Q3	$304K	Sell	3,080 -297	-9%	-$29.2K	0.15%	94
2024 Q2	$313K	Sell	3,377 -305	-8%	-$27.3K	0.17%	106
2024 Q1	$349K	Sell	3,682 -188	-5%	-$17.4K	0.21%	91
2023 Q4	$346K	Buy	3,870 +203	+6%	+$15.1K	0.23%	95
2023 Q3	$268K	Buy	+3,667	New	+$293K	0.2%	105

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Avaii Wealth Management's XBI Position: Q1 2026 in Review

Avaii Wealth Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 62% in Q1 2026, selling an estimated $345K and leaving 1,674 shares worth $214K. The position accounts for 0.07% of the portfolio, ranked #152.

Avaii Wealth Management first reported a position in XBI in Q3 2023 and has held it in 11 quarters since. The position peaked at $541K in Q4 2025. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Avaii Wealth Management held 1,674 shares of State Street SPDR S&P Biotech ETF worth $214K as of Q1 2026.
Avaii Wealth Management sold 2,765 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $345K.
State Street SPDR S&P Biotech ETF made up 0.07% of Avaii Wealth Management's portfolio in Q1 2026, its #152 holding.
Avaii Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and has held it in 11 quarters since.
Avaii Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $541K in Q4 2025.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Avaii Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.